Shotsy is an innovative mobile app created by Aja Beckett for users of GLP-1 medications such as Ozempic and Wegovy. Frustrated with long and messy note-taking, Beckett developed Shotsy, which has gained significant traction, including over 100,000 downloads and a profitable revenue run rate of $1 million. The app currently offers a free version and a subscription for enhanced features. With $2.25 million in recent seed funding, funding will focus on marketing and team expansion amidst growing interest in weight-loss solutions.
When Aja Beckett started using a GLP-1 medication, she took notes on her phone to track her doses, side effects, and hunger.
Shotsy has been downloaded over 100,00 times and has reached a revenue run rate of $1 million - a projection of yearly revenue based on current revenue numbers.
The app is available to download and use for free and offers additional features that can be accessed through a $19.99 annual subscription.
Investors are taking notice. Shotsy has raised $2.25 million in seed funding to ramp up marketing and grow its team.
Collection
[
|
...
]